Matches in Nanopublications for { ?s ?p "[Our results indicated that Src kinase is pathogenically activated in lymphomagenesis induced by FGFR1 fusion genes, implying that Src kinase inhibitors may offer a useful option to treatment of FGFR1-associated myeloproliferative/lymphoma disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Our results indicated that Src kinase is pathogenically activated in lymphomagenesis induced by FGFR1 fusion genes, implying that Src kinase inhibitors may offer a useful option to treatment of FGFR1-associated myeloproliferative/lymphoma disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP400340.RAln6eyNpWx1ja4OjI3X0KAEchF0QEAWuKZiaSJmpMJ0g130_assertion description "[Our results indicated that Src kinase is pathogenically activated in lymphomagenesis induced by FGFR1 fusion genes, implying that Src kinase inhibitors may offer a useful option to treatment of FGFR1-associated myeloproliferative/lymphoma disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400340.RAln6eyNpWx1ja4OjI3X0KAEchF0QEAWuKZiaSJmpMJ0g130_provenance.
- NP925536.RANPHeDpQacvzmJHBpHw7jyQQAk9bGaAXDWTeNzNQt2XY130_assertion description "[Our results indicated that Src kinase is pathogenically activated in lymphomagenesis induced by FGFR1 fusion genes, implying that Src kinase inhibitors may offer a useful option to treatment of FGFR1-associated myeloproliferative/lymphoma disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925536.RANPHeDpQacvzmJHBpHw7jyQQAk9bGaAXDWTeNzNQt2XY130_provenance.